4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill - Organigram Global (NASDAQ:OGI), Cronos Group (NASDAQ:CRON)
Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.
How this was made

The 30-second read
Why it matters
Despite these headwinds, technical momentum suggests trader optimism, possibly driven by sector resilience or speculative trading.
Market read
Sector exhibits resilience despite regulatory setbacks, with select stocks showing technical strength.
What to watch
Potential delays in regulatory decisions or broader market downturns could adversely affect these stocks.
Background
Recent legislative developments re-criminalizing certain THC products in the US have introduced regulatory headwinds for cannabis stocks.
Ticker impact
High relevance due to positive sentiment and recent momentum.
Moderate upward movement in the next 1-2 weeks.
Technical indicators suggest momentum; however, regulatory risks could temper gains.
High relevance with somewhat bullish sentiment and recent momentum.
Potential modest increase over the next 1-2 weeks.
Technical signals are favorable, but external headwinds may limit gains.
Market effects
Potential positive sentiment for the cannabis sector despite regulatory headwinds.
Limited regional impact; primarily US-based stocks affected.
Minimal global relevance; sector-specific news.
Counterpoint
Regulatory headwinds may intensify, leading to sharp declines in cannabis stocks, negating recent momentum.
Key entities
- GovernmentCongress
US Congress re-criminalized some THC products in a recent spending bill.
- CompanyOrganigram Global
Cannabis producer demonstrating momentum.
- CompanyCronos Group
Cannabis company showing technical strength.
- CompanyTLRY
Cannabis company with neutral sentiment.
- CompanySNDL
Cannabis company with limited momentum.
